FREE SHIPPING ON ORDERS OVER $150

royal pharmaceuticals tirzepatide Weight Loss Injections Mounjaro approved for use in

$21.55

Quantity
- +
Description

In the SURMOUNT-1 trial, adults with obesity or overweight with weight-related conditions (but without diabetes) experienced average weight loss of 15-20% after 72 weeks, depending on dosage

royal pharmaceuticals tirzepatide Weight Loss Injections Mounjaro approved for use in

Immunologic And Local Reactions: Injection Site And Allergic Reactions Local reactions such as redness, itching, and mild swelling at the injection site occur commonly and resolve within days

royal pharmaceuticals tirzepatide Weight Loss Injections Mounjaro approved for use in

Increased heart rate Some Mounjaro trial participants experienced an average increased heart rate of 2 to 4 beats per minute, compared to 1 beat per minute in the placebo group

royal pharmaceuticals tirzepatide Weight Loss Injections Mounjaro approved for use in

The first month brought some mild stomach discomfort and reduced appetite

royal pharmaceuticals tirzepatide Weight Loss Injections Mounjaro approved for use in

If youre also taking insulin or other diabetes medications, watch for symptoms of low blood sugar, including shakiness, sweating, confusion, or a rapid heartbeat

royal pharmaceuticals tirzepatide Weight Loss Injections Mounjaro approved for use in

Insoluble fiber should be introduced cautiously as it may increase bloating and gas in some individuals, potentially compounding tirzepatide's gastrointestinal effects

royal pharmaceuticals tirzepatide Weight Loss Injections Mounjaro approved for use in

You may also like

recommand products